SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-21-002515
Filing Date
2021-02-11
Accepted
2021-02-11 09:17:26
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 govx20210210b_424b5.htm 424B5 516689
2 govx20210122_s3img001.jpg GRAPHIC 7891
3 govx20210122_s3img002.jpg GRAPHIC 8956
4 govx20210122_s3img003.gif GRAPHIC 13890
5 zimk3p4od424b5img001.jpg GRAPHIC 7774
6 zimk3p4od424b5img002.jpg GRAPHIC 8794
7 zimk3p4od424b5img003.gif GRAPHIC 14107
8 zsoocvkqx424b5img001.jpg GRAPHIC 7774
  Complete submission text file 0001437749-21-002515.txt   614234
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252437 | Film No.: 21617101
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences